We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$6.45B
Cap. Flow %
0.91%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.77%
2 Consumer Discretionary 1.94%
3 Technology 1.9%
4 Communication Services 1.42%
5 Financials 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNRH
9301
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
$543K ﹤0.01%
55,849
-15,361
-22% -$151K
TCRR
9302
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$543K ﹤0.01%
33,069
+6,787
+26% +$137K
ACLS icon
9303
PUT
Axcelis
ACLS
$3.57B
$542K ﹤0.01%
13,400
-7,200
-35% -$298K
EVER icon
9304
PUT
EverQuote
EVER
$904M
$542K ﹤0.01%
16,600
+6,500
+64% +$217K
HTHT icon
9305
Huazhu Hotels Group
HTHT
$14.7B
$542K ﹤0.01%
10,250
-20,357
-67% -$1.15M
PVLA
9306
CALL
Palvella Therapeutics
PVLA
$2.16B
$542K ﹤0.01%
+1,768
New +$388K
GALT icon
9307
PUT
Galectin Therapeutics
GALT
$405M
$541K ﹤0.01%
169,100
+90,600
+115% +$322K
INGN icon
9308
CALL
Inogen
INGN
$146M
$541K ﹤0.01%
8,300
-100
-1% -$6.33K
MBI icon
9309
MBIA
MBI
$244M
$541K ﹤0.01%
+49,148
New +$490K
MBI icon
9310
PUT
MBIA
MBI
$244M
$541K ﹤0.01%
49,200
-63,500
-56% -$633K
PLX icon
9311
Protalix BioTherapeutics
PLX
$205M
$541K ﹤0.01%
283,145
+79,332
+39% +$273K
PSEP icon
9312
Innovator US Equity Power Buffer ETF September
PSEP
$817M
$541K ﹤0.01%
18,374
+10,879
+145% +$318K
XHR
9313
Xenia Hotels & Resorts
XHR
$1.8B
$541K ﹤0.01%
28,905
+10,035
+53% +$193K
QTS
9314
PUT
DELISTED
QTS REALTY TRUST, INC.
QTS
$541K ﹤0.01%
7,000
+2,100
+43% +$143K
BCO icon
9315
Brink's
BCO
$4.57B
$540K ﹤0.01%
7,030
-1,016
-13% -$78.9K
LGTY
9316
CALL
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$540K ﹤0.01%
+24,600
New +$518K
ECHO
9317
DELISTED
Echo Global Logistics, Inc.
ECHO
$540K ﹤0.01%
+17,569
New +$580K
NORW
9318
DELISTED
Global X MSCI Norway ETF
NORW
$540K ﹤0.01%
+37,982
New +$553K
LGLV icon
9319
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.22B
$539K ﹤0.01%
4,047
-16,448
-80% -$2.17M
RFV icon
9320
Invesco S&P MidCap 400 Pure Value ETF
RFV
$339M
$539K ﹤0.01%
5,860
+1,289
+28% +$122K
YMAB
9321
DELISTED
Y-mAbs Therapeutics
YMAB
$539K ﹤0.01%
15,947
-3,379
-17% -$108K
ONEM
9322
DELISTED
1Life Healthcare
ONEM
$539K ﹤0.01%
16,291
-45,357
-74% -$1.71M
ZWRKU
9323
DELISTED
Z-Work Acquisition Corp. Units
ZWRKU
$539K ﹤0.01%
53,923
BATRA icon
9324
Atlanta Braves Holdings Series A
BATRA
$3.58B
$538K ﹤0.01%
19,052
+7,779
+69% +$217K
RBC icon
9325
PUT
RBC Bearings
RBC
$15.8B
$538K ﹤0.01%
+2,700
New +$533K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.